Paraoxonase 1 (PON1) status and substrate hydrolysis
- 13 November 2008
- journal article
- Published by Elsevier BV in Toxicology and Applied Pharmacology
- Vol. 235 (1), 1-9
- https://doi.org/10.1016/j.taap.2008.11.001
Abstract
No abstract availableThis publication has 50 references indexed in Scilit:
- Determination of Paraoxonase 1 Status Without the Use of Toxic Organophosphate SubstratesCirculation: Cardiovascular Genetics, 2008
- Drosophila are protected from Pseudomonas aeruginosa lethality by transgenic expression of paraoxonase-1JCI Insight, 2008
- Human paraoxonase: A promising approach for pre-treatment and therapy of organophosphorus poisoningToxicology, 2007
- Future Studies of Low-Activity PON1 Phenotype Subjects May Reveal How PON1 Protects Against Cardiovascular DiseaseArteriosclerosis, Thrombosis, and Vascular Biology, 2003
- Paraoxonase Activity, But Not Haplotype Utilizing the Linkage Disequilibrium Structure, Predicts Vascular DiseaseArteriosclerosis, Thrombosis, and Vascular Biology, 2003
- Paraoxonase-1 promoter haplotypes and serum paraoxonase: a predominant role for polymorphic position −107, implicating the Sp1 transcription factorBiochemical Journal, 2003
- SIMULATED DERMAL CONTAMINATION WITH CAPILLARY SAMPLES AND FIELD CHOLINESTERASE BIOMONITORINCJournal of Toxicology and Environmental Health, 1997
- Paraoxonase protects against chlorpyrifos toxicity in miceToxicology Letters, 1995
- Role of detoxication pathways in acute toxicity levels of phosphorothionate insecticides in the ratLife Sciences, 1994
- Serum paraoxonase status: A major factor in determining resistance to organophosphatesJournal of Toxicology and Environmental Health, 1993